Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Wyeth-Ayerst Crinone comparative claims in press release are misleading -- FDA ad division.

Executive Summary

WYETH-AYERST CRINONE PRESS RELEASE DISSEMINATION DESPITE DDMAC WARNING draws May 19 letter from FDA's Division of Drug Marketing, Advertising & Communications to Wyeth-Ayerst Associate Director of Regulatory Affairs Joan Barton. DDMAC Regulatory Review Officer Lisa Stockbridge, PhD, reminded Barton: "I told you that I had concerns about at least one presentation before I had finished the first read of the press release."
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS030346

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel